U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 5,301 records

Showing results for "laboratory".

  1. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - sophisticated, costly infrastructure in the form of hybrid operating rooms or hybrid catheterization laboratories

  2. Disposition of Comments for Technical Brief 20 Core Functionality in Pediatric Electronic Health Records (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
    May 01, 2015 - We have reworded the paragraph to emphasize the importance of laboratory data with interpretation displayed

  3. Breast-Cancer-Imaging Technical-Brief (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
    October 01, 2014 - abdomen, and bone in addition to obtaining medical histories, physical examinations, and relevant laboratory

  4. Bariatric Surgery in Women of Reproductive Age: Special Concerns for Pregnancy. Evidence Report/Technology Assessment, No. 169 (pdf file)

    www.ahrq.gov/downloads/pub/evidence/pdf/bariatricrep/barirep.pdf
    November 01, 2008 - levels of serum testosterone and dehydroepiandrosterone sulfate (DHEA-S).38 In addition to the direct laboratory

  5. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
    May 29, 2025 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  6. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  7. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  8. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
    July 13, 2021 - b The guidelines note this test should be performed in a laboratory using a method that is National

  9. Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
    May 01, 2012 - settings to be clinics similar to where most patients are seen, rather than academic health centers, laboratory

  10. Making Healthcare Safer IV Rapid Review: Patient Monitoring Systems To Prevent Failure To Rescue (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
    December 01, 2024 - learning-generated alerts using the Modified Early Warning Score (MEWS++) system, which integrates EMR, laboratory

  11. Gestational-Diabetes-Screening-Diagnosis Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
    October 01, 2012 - These criteria reflect changes that have occurred in laboratory glucose measurements over the years

  12. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
    November 27, 2012 - Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus.

  13. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
    January 01, 2022 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  14. Infectious Disease Including HIV/AIDS #09 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
    January 01, 2012 - Gold test), and/or chest x-ray results. 173,174 The current recommended diagnostic procedure for laboratory

  15. Cannabis-2023-Surv-Rep-1-App-F (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
    January 01, 2023 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  16. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
    January 01, 2022 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  17. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
    January 01, 2023 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory

  18. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
    March 01, 2011 - A third trial reported that there was no clinical or laboratory evidence of contrast- induced nephropathy

  19. Antiplatelet-Treatment Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
    September 01, 2013 - over ascertainment of conventional risk factors in the populations of interest (e.g., clinical or laboratory

  20. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short Other (laboratory
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (2415)

www.ahrq.gov (1049)

digital.ahrq.gov (800)

effectivehealthcare.ahrq.gov (425)

hcup-us.ahrq.gov (276)

www.uspreventiveservicestaskforce.org (247)

meps.ahrq.gov (32)

cds.ahrq.gov (22)

cdsic.ahrq.gov (17)

integrationacademy.ahrq.gov (12)

pso.ahrq.gov (5)

datatools.ahrq.gov (1)